NO20021049L - Nye chalkoner - Google Patents

Nye chalkoner

Info

Publication number
NO20021049L
NO20021049L NO20021049A NO20021049A NO20021049L NO 20021049 L NO20021049 L NO 20021049L NO 20021049 A NO20021049 A NO 20021049A NO 20021049 A NO20021049 A NO 20021049A NO 20021049 L NO20021049 L NO 20021049L
Authority
NO
Norway
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Application number
NO20021049A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021049D0 (no
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20021049D0 publication Critical patent/NO20021049D0/no
Publication of NO20021049L publication Critical patent/NO20021049L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20021049A 1999-09-03 2002-03-01 Nye chalkoner NO20021049L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Publications (2)

Publication Number Publication Date
NO20021049D0 NO20021049D0 (no) 2002-03-01
NO20021049L true NO20021049L (no) 2002-05-03

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021049A NO20021049L (no) 1999-09-03 2002-03-01 Nye chalkoner

Country Status (21)

Country Link
US (1) US6620842B2 (https=)
EP (1) EP1212315B1 (https=)
JP (1) JP2003508527A (https=)
KR (1) KR100819576B1 (https=)
CN (1) CN1177843C (https=)
AT (1) ATE235483T1 (https=)
AU (1) AU776226B2 (https=)
CA (1) CA2382130A1 (https=)
CZ (1) CZ2002787A3 (https=)
DE (1) DE60001851T2 (https=)
DK (1) DK1212315T3 (https=)
ES (1) ES2193106T3 (https=)
GB (1) GB9920910D0 (https=)
HK (1) HK1043999B (https=)
HU (1) HUP0202579A3 (https=)
NO (1) NO20021049L (https=)
PL (1) PL353064A1 (https=)
PT (1) PT1212315E (https=)
RU (1) RU2252938C2 (https=)
SK (1) SK3112002A3 (https=)
WO (1) WO2001017988A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003234733B2 (en) 2002-04-17 2009-01-29 Cytokinetics, Inc. Compounds, compositions, and methods
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
JP2005533119A (ja) 2002-07-17 2005-11-04 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
WO2013127361A1 (en) * 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006921A1 (en) * 1988-12-21 1990-06-28 The Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
WO1991017749A1 (en) * 1990-05-17 1991-11-28 Baylor College Of Medicine Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
EP1212315B1 (en) 2003-03-26
GB9920910D0 (en) 1999-11-10
DK1212315T3 (da) 2003-06-23
ES2193106T3 (es) 2003-11-01
NO20021049D0 (no) 2002-03-01
DE60001851D1 (de) 2003-04-30
WO2001017988A1 (en) 2001-03-15
JP2003508527A (ja) 2003-03-04
US6620842B2 (en) 2003-09-16
HUP0202579A3 (en) 2003-07-28
CN1177843C (zh) 2004-12-01
CA2382130A1 (en) 2001-03-15
EP1212315A1 (en) 2002-06-12
SK3112002A3 (en) 2003-10-07
HK1043999B (en) 2003-08-15
KR20020031598A (ko) 2002-05-02
KR100819576B1 (ko) 2008-04-22
CN1371372A (zh) 2002-09-25
ATE235483T1 (de) 2003-04-15
PT1212315E (pt) 2003-08-29
HUP0202579A2 (hu) 2002-11-28
AU7510900A (en) 2001-04-10
US20030055056A1 (en) 2003-03-20
DE60001851T2 (de) 2003-12-11
RU2252938C2 (ru) 2005-05-27
HK1043999A1 (en) 2002-10-04
AU776226B2 (en) 2004-09-02
CZ2002787A3 (cs) 2002-06-12
PL353064A1 (en) 2003-10-06

Similar Documents

Publication Publication Date Title
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
PL367682A1 (en) Dolastatin 10 derivatives
DK1233770T3 (da) Phosphonatforbindelser
NO20012975D0 (no) Nye bifenyl og bifenylanaloge forbindelser som integrinantagonister
TR200002557T2 (tr) İntegrin reseptörü antagonistleri
BG105161A (en) Benzocycloheptenes, methods for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AP2001002143A0 (en) Substituted benzopyran analogs for the treatment of inflamation
ATE374609T1 (de) Synthese von 4-aminothalidomid enantiomeren
HN1997000052A (es) Nuevas 4(3h)--quinazolinas 2,3-disustituidas
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
GB0225475D0 (en) Therapeutic agents
NO20021050L (no) Nye derivater av flavoner, xantoner og kumariner
AP2000001898A0 (en) Vitronectin receptor antagonists
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
NZ512292A (en) Sulfonamide hydroxamates that inhibit procollagen C- proteinase
NO20021049D0 (no) Nye chalconer
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
EP1534284A4 (en) AMINO-SUBSTITUTED SULPHONANILIDES AND THEIR DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
DE69934113D1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
DE60113418D1 (de) Anti-karzinogene aktivität von aus der lakritzenwurzel isolierten hydroxylierten chalcon-verbindungen
MXPA04001855A (es) Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
DE69822861D1 (de) Bentzothiophene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application